Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results

Dow Jones biotech giant Amgen stock is trying to break out past a new buy point ahead of the firm's Q3 earnings report. The post Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results appeared first on Investor's Business Daily.